Clin Exp Otorhinolaryngol.  2019 Nov;12(4):412-419. 10.21053/ceo.2018.01774.

Tobacco Smoking and Alcohol Consumption Are Related to Benign Parotid Tumor: A Nested Case-Control Study Using a National Health Screening Cohort

• Kim SY
• Min C
• Oh DJ
• Choi HG

• KMID: 2462738
• DOI: http://doi.org/10.21053/ceo.2018.01774

Abstract

OBJECTIVES
To evaluate the relationship among smoking, alcohol consumption, and obesity and benign or malignant parotid tumors in a Korean population.
METHODS
The Korean National Health Insurance Service-Health Screening Cohort (for ≥40-year-olds) was assessed from 2002 to 2013. In total, 336 benign parotid tumors and 46 malignant parotid tumors were matched with controls at a ratio of 1 to 4 with respect to age, sex, income, region of residence, hypertension, diabetes, and dyslipidemia. We analyzed previous histories of smoking, alcohol consumption, and obesity. By unconditional logistic regression analyses, the crude and adjusted odds ratios (ORs) were investigated and the 95% confidence intervals (CIs) were counted.
RESULTS
The estimated annual incidence of the benign parotid tumors was 5.66 per 100,000, and that of the malignant parotid tumor was 0.81 per 100,000. The adjusted ORs of smoking for the benign parotid tumors was 2.52 (95% CI, 1.84 to 3.46). This finding was consistent in the subgroups of <60 years old, ≥60 years old, and men. The adjusted ORs of alcohol consumption for the benign parotid tumors showed the statistical significance only in women (adjusted OR, 2.35; 95% CI, 1.10 to 5.00). Obesity did not reach a statistical significance in any analysis.
CONCLUSION
Benign parotid tumor was related with smoking, and it was linked with alcohol consumption in women only.

Keyword

Tobacco; Smoking; Alcohol; Ethanol; Parotid; Salivary Gland

MeSH Terms

Alcohol Drinking*
Case-Control Studies*
Cohort Studies*
Dyslipidemias
Ethanol
Female
Humans
Hypertension
Incidence
Logistic Models
Male
Mass Screening*
National Health Programs
Obesity
Odds Ratio
Salivary Glands
Smoke
Smoking*
Tobacco*
Ethanol
Smoke

Figure

• 

  Fig. 1. Schematic illustration of the participant selection process used in the present study. Of a total of 514,866 participants, 336 benign parotid tumor patients were matched with 1,344 control I participants (A), and 46 malignant parotid tumor patient were also matched with 184 control II participants (B) based on age, sex, income, region of residence, and past medical history.

Reference

1. Laurie SA. Salivary gland tumors: epidemiology, diagnosis, evaluation, and staging [Internet]. Waltham, MA: UpToDate;2019 [cited 2019 Mar 24]. Available from: https://www.uptodate.com/contents/salivary-gland-tumors-epidemiology-diagnosis-evaluation-andstaging?search=Salivary%20gland%20tumors:%20Epidemiology,%20diagnosis,%20evaluation,%20and%20staging&source=search_result&selectedTitle=1~34&usage_type=default&display_rank=1.

2. Bailey BJ, Calhoun KH. Atlas of head & neck surgery: otolaryngology. New York, NY: Lippincott Williams & Wilkins;2001.

3. Bradley PJ, McGurk M. Incidence of salivary gland neoplasms in a defined UK population. Br J Oral Maxillofac Surg. 2013; Jul. 51(5):399–403.

4. Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg. 1999; Jun. 120(6):834–40.

5. Barnes L, Eveson JW, Reichart P, Sidransky D. Pathology and genetics of head and neck tumours. Lyon: IARC Press;2005.

6. Sadetzki S, Chetrit A, Jarus-Hakak A, Cardis E, Deutch Y, Duvdevani S, et al. Cellular phone use and risk of benign and malignant parotid gland tumors: a nationwide case-control study. Am J Epidemiol. 2008; Feb. 167(4):457–67.

7. Shebl FM, Bhatia K, Engels EA. Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States. Int J Cancer. 2010; May. 126(10):2503–8.

8. Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017; Apr. 46(2):e15.

9. Van Cauwenberge P, Van Hoecke H, Kardos P, Price D, Waserman S. The current burden of allergic rhinitis amongst primary care practitioners and its impact on patient management. Prim Care Respir J. 2009; Mar. 18(1):27–33.

10. National Health Insurance Service. National Health Insurance Sharing Service [Internet]. Wonju: National Health Insurance Service;2019 [cited 2019 Mar 24]. Available from: https://nhiss.nhis.or.kr/bd/ab/bdaba001cv.do.

11. Song SO, Jung CH, Song YD, Park CY, Kwon HS, Cha BS, et al. Background and data configuration process of a nationwide population-based study using the korean national health insurance system. Diabetes Metab J. 2014; Oct. 38(5):395–403.

12. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia;2000.

13. Sadetzki S, Oberman B, Mandelzweig L, Chetrit A, Ben-Tal T, JarusHakak A, et al. Smoking and risk of parotid gland tumors: a nationwide case-control study. Cancer. 2008; May. 112(9):1974–82.

14. Spitz MR, Fueger JJ, Goepfert H, Newell GR. Salivary gland cancer: a case-control investigation of risk factors. Arch Otolaryngol Head Neck Surg. 1990; Oct. 116(10):1163–6.

15. Yu GY, Liu XB, Li ZL, Peng X. Smoking and the development of Warthin’s tumour of the parotid gland. Br J Oral Maxillofac Surg. 1998; Jun. 36(3):183–5.

16. Kotwall CA. Smoking as an etiologic factor in the development of Warthin’s tumor of the parotid gland. Am J Surg. 1992; Dec. 164(6):646–7.

17. Lee YM, Choi HJ, Kim JW, Kim JH. Parotid gland tumors in a Korean population. J Craniofac Surg. 2012; May. 23(3):e205–9.

18. Moeller K, Esser D, Boeger D, Buentzel J, Hoffmann K, Jecker P, et al. Parotidectomy and submandibulectomy for benign diseases in Thuringia, Germany: a population-based study on epidemiology and outcome. Eur Arch Otorhinolaryngol. 2013; Mar. 270(3):1149–55.

19. Gove WR, Hughes M. Possible causes of the apparent sex differences in physical health: an empirical investigation. Am Sociol Rev. 1979; Feb. 44(1):126–46.

20. Gunn A, Parrott NR. Parotid tumours: a review of parotid tumour surgery in the Northern Regional Health Authority of the United Kingdom 1978-1982. Br J Surg. 1988; Nov. 75(11):1144–6.

21. Pinkston JA, Cole P. Cigarette smoking and Warthin’s tumor. Am J Epidemiol. 1996; Jul. 144(2):183–7.

22. Horn-Ross PL, Ljung BM, Morrow M. Environmental factors and the risk of salivary gland cancer. Epidemiology. 1997; Jul. 8(4):414–9.

23. Zheng W, Shu XO, Ji BT, Gao YT. Diet and other risk factors for cancer of the salivary glands: a population-based case-control study. Int J Cancer. 1996; Jul. 67(2):194–8.

24. Muscat JE, Wynder EL. A case/control study of risk factors for major salivary gland cancer. Otolaryngol Head Neck Surg. 1998; Feb. 118(2):195–8.

25. Spitz MR, Tilley BC, Batsakis JG, Gibeau JM, Newell GR. Risk factors for major salivary gland carcinoma: a case-comparison study. Cancer. 1984; Nov. 54(9):1854–9.

26. Radoi L, Barul C, Menvielle G, Carton M, Matrat M, Sanchez M, et al. Risk factors for salivary gland cancers in France: results from a case-control study, the ICARE study. Oral Oncol. 2018; May. 80:56–63.

27. Pan SY, de Groh M, Morrison H. A case-control study of risk factors for salivary gland cancer in Canada. J Cancer Epidemiol. 2017; 2017:4909214.

28. Suba Z, Barabas J, Szabo G, Takacs D, Ujpal M. Increased prevalence of diabetes and obesity in patients with salivary gland tumors. Diabetes Care. 2005; Jan. 28(1):228.

29. Maier H, Born IA, Mall G. Effect of chronic ethanol and nicotine consumption on the function and morphology of the salivary glands. Klin Wochenschr. 1988; 66 Suppl 11:140–50.

30. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. Alcohol consumption and the risk of cancer: a meta-analysis. Alcohol Res Health. 2001; 25(4):263–70.